Assessing the cost-effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus: A comprehensive economic evaluation using clinical trial and real-world evidence.

Phil McEwanHayley BennettKamlesh KhuntiJohn P H WildingChristopher EdmondsMarcus ThuressonEric T WittbrodtPeter FeniciMikhail Naum Kosiborod

Published in: Diabetes, obesity & metabolism (2020)

The findings highlight the need to take into account cost savings from reducing common, morbid and preventable T2DM complications when considering the cost of diabetes medications.

Keyphrases

clinical trial
glycemic control
type diabetes
cardiovascular disease
bariatric surgery
risk factors
open label
phase ii
study protocol
double blind
emergency department
randomized controlled trial
obese patients
adverse drug
phase iii
electronic health record